Literature DB >> 12598496

Cognitive development at 5.5 years of children with chronic lung disease of prematurity.

B Böhm1, M Katz-Salamon.   

Abstract

BACKGROUND: Preterm infants with chronic lung disease (CLD) had impaired cognitive development and poorer eye-hand coordination at 10 months of age. AIMS: To study whether this effect of CLD persisted until school age and whether the severity of CLD affected outcome.
METHOD: Cognition and visual-motor skills were examined (Wechsler preschool and primary scale of intelligence, and tests from the Nepsy scale) in 60 very preterm children, without intraventricular haemorrhage or periventricular leucomalacia, at 5.5 years of age. Thirty two children suffered from CLD and 28 were controls.
RESULTS: The groups did not differ significantly in cognitive outcome. Children with CLD and controls attained a full scale intelligence quotient (IQ) of 94.4 and 99.1, a verbal IQ of 99.6 and 101.5, and a performance IQ of 90.9 and 96.7 respectively. Similarly, no difference was found in tests of eye-hand control. However, the children with the most severe form of CLD had significantly lower performance (84.8) and full scale(87.6) IQs and worse visual-motor performance than the controls. CLD grade III, together with the need for glasses or lenses, had a significant impact on the explained variance.
CONCLUSIONS: At school age, children born very preterm and who experienced severe CLD had deficits in cognition, visual-motor perception, and performance. The findings suggest a need to consider intervention programmes for such infants.

Entities:  

Mesh:

Year:  2003        PMID: 12598496      PMCID: PMC1721516          DOI: 10.1136/fn.88.2.f101

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  21 in total

1.  Brain lesions in preterms: origin, consequences and compensation.

Authors:  I Krägeloh-Mann; P Toft; J Lunding; J Andresen; O Pryds; H C Lou
Journal:  Acta Paediatr       Date:  1999-08       Impact factor: 2.299

2.  Leptin and puberty.

Authors:  P E Clayton; J A Trueman
Journal:  Arch Dis Child       Date:  2000-07       Impact factor: 3.791

3.  Sleep apnea and hypoxemia in recently weaned premature infants with and without bronchopulmonary dysplasia.

Authors:  K C Sekar; J C Duke
Journal:  Pediatr Pulmonol       Date:  1991

4.  Bronchopulmonary dysplasia: clinical presentation.

Authors:  E Bancalari; G E Abdenour; R Feller; J Gannon
Journal:  J Pediatr       Date:  1979-11       Impact factor: 4.406

5.  Clinical and roentgenographic scoring systems for assessing bronchopulmonary dysplasia.

Authors:  S S Toce; P M Farrell; L A Leavitt; D P Samuels; D K Edwards
Journal:  Am J Dis Child       Date:  1984-06

6.  Oxygen saturation during sleep in patients with bronchopulmonary dysplasia.

Authors:  R Zinman; P W Blanchard; F Vachon
Journal:  Biol Neonate       Date:  1992

7.  Birthweight between 14 and 42 weeks' gestation.

Authors:  D V Keen; R G Pearse
Journal:  Arch Dis Child       Date:  1985-05       Impact factor: 3.791

8.  Increased risk of cerebral palsy among very low-birthweight infants with chronic lung disease.

Authors:  M D Skidmore; A Rivers; M Hack
Journal:  Dev Med Child Neurol       Date:  1990-04       Impact factor: 5.449

9.  Regressed retinopathy of prematurity and its sequelae in children aged 5-10 years.

Authors:  J E Gallo; G Holmström; U Kugelberg; B Hedquist; G Lennerstrand
Journal:  Br J Ophthalmol       Date:  1991-09       Impact factor: 4.638

Review 10.  The adverse neuro-developmental effects of postnatal steroids in the preterm infant: a systematic review of RCTs.

Authors:  K J Barrington
Journal:  BMC Pediatr       Date:  2001-02-27       Impact factor: 2.125

View more
  8 in total

1.  Risk factors affecting school readiness in premature infants with respiratory distress syndrome.

Authors:  Athena I Patrianakos-Hoobler; Michael E Msall; Jeremy D Marks; Dezheng Huo; Michael D Schreiber
Journal:  Pediatrics       Date:  2009-07       Impact factor: 7.124

2.  Health Care and Societal Costs of Bronchopulmonary Dysplasia.

Authors:  Wannasiri Lapcharoensap; Henry C Lee; Amy Nyberg; Dmitry Dukhovny
Journal:  Neoreviews       Date:  2018-04

3.  Cognitive outcomes for extremely preterm/extremely low birth weight children in kindergarten.

Authors:  Leah J Orchinik; H Gerry Taylor; Kimberly Andrews Espy; Nori Minich; Nancy Klein; Tiffany Sheffield; Maureen Hack
Journal:  J Int Neuropsychol Soc       Date:  2011-09-19       Impact factor: 2.892

4.  Influence of own mother's milk on bronchopulmonary dysplasia and costs.

Authors:  Aloka L Patel; Tricia J Johnson; Beverley Robin; Harold R Bigger; Ashley Buchanan; Elizabeth Christian; Vikram Nandhan; Anita Shroff; Michael Schoeny; Janet L Engstrom; Paula P Meier
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2016-11-02       Impact factor: 5.747

5.  The EPICure study: associations and antecedents of neurological and developmental disability at 30 months of age following extremely preterm birth.

Authors:  N S Wood; K Costeloe; A T Gibson; E M Hennessy; N Marlow; A R Wilkinson
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2005-03       Impact factor: 5.747

6.  Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus.

Authors:  Yuri Hiramatsu; Kentaro Isoda; Takuya Kotani; Eri Nakamura; Yumiko Wada; Youhei Fujiki; Shigeki Makino; Daisuke Fujita; Tohru Takeuchi
Journal:  Arthritis Res Ther       Date:  2021-05-12       Impact factor: 5.156

7.  Functional Analysis of Bronchopulmonary Dysplasia-Related Neuropeptides in Preterm Infants and miRNA-Based Diagnostic Model Construction.

Authors:  Yue Zhang; Xiangyong Kong; Jie Zhang; Xu Wang
Journal:  Comput Math Methods Med       Date:  2022-04-25       Impact factor: 2.809

8.  The role of nutrition in promoting growth in pre-term infants with bronchopulmonary dysplasia: a prospective non-randomised interventional cohort study.

Authors:  Maria Lorella Giannì; Paola Roggero; Maria Rosa Colnaghi; Pasqua Piemontese; Orsola Amato; Anna Orsi; Laura Morlacchi; Fabio Mosca
Journal:  BMC Pediatr       Date:  2014-09-22       Impact factor: 2.125

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.